Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 474 (RNA5SP474) is classified as a pseudogene derived from 5S ribosomal RNA (rRNA)[1][4]. Pseudogenes are non-functional genomic DNA sequences similar to functional genes but are typically incapable of encoding proteins due to disabling mutations or the absence of regulatory elements[2][4]. RNA5SP474 is a processed rRNA pseudogene, meaning it lacks introns and is thought to result from retrotransposition events[4]. While functional 5S rRNA is a key structural component of the large ribosomal subunit and is involved in ribosome assembly and protein synthesis[3][5], RNA5SP474 itself does not encode a functional RNA or protein and has no characterized biological function or role in disease. There is also no evidence linking RNA5SP474 to drug interactions, therapeutic targeting, or biomarker usage[1]. This locus is annotated in genomic databases but is not considered a therapeutic target, receptor, enzyme, or relevant molecular target in pharmacology or medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 474 (RNA5SP474).